A PKM2 signature in the failing heart

Biochemical and Biophysical Research Communications

Volumn 459, Issue 3, 2015, Pages 430-436

  Rees, Meredith L ^a   Subramaniam, Janani ^a   Li, Yuanteng ^a   Hamilton, Dale J ^b   Frazier, O Howard ^c   Taegtmeyer, Heinrich ^a,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c TEXAS HEART INSTITUTE   (United States)

Author keywords

Fetal gene program; Glycolysis; Heart failure; Hif1 ; PKM2; Sunitinib

Indexed keywords

ANGIOGENESIS INHIBITOR; CARRIER PROTEIN; GLUCOSE; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDOLE DERIVATIVE; MEMBRANE PROTEIN; PYRROLE DERIVATIVE; PYRUVATE KINASE; SUNITINIB; THYROID HORMONE; THYROID HORMONE-BINDING PROTEINS;

ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; DRUG EFFECTS; FETUS HEART; GENE EXPRESSION; GENETICS; GLYCOLYSIS; HEART; HEART FAILURE; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MOUSE;

ANGIOGENESIS INHIBITORS; ANIMALS; CARRIER PROTEINS; FETAL HEART; GENE EXPRESSION; GLUCOSE; GLYCOLYSIS; HEART; HEART FAILURE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDOLES; INSULIN RESISTANCE; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MYOCARDIUM; MYOCYTES, CARDIAC; PYRROLES; PYRUVATE KINASE; THYROID HORMONES;

EID: 84939940590     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.02.122     Document Type: Article

References (32)

1. W.C. Stanley, F.A. Recchia, and G.D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart 2005
2. H. Taegtmeyer, S. Sen, and D. Vela Return to the fetal gene program: a suggested metabolic link to gene expression in the heart Ann. N. Y. Acad. Sci. 1188 2010 191 198
3. P. Razeghi, M.E. Young, J.L. Alcorn, C.S. Moravec, O.H. Frazier, and H. Taegtmeyer Metabolic gene expression in fetal and failing human heart Circulation 104 2001 2923 2931
4. N.M. Agostino, V.M. Chinchilli, C.J. Lynch, A. Koszyk-Szewczyk, R. Gingrich, J. Sivik, and J.J. Drabick Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice J. Oncol. Pharm. Pract. 17 2011 197 202
5. B. Billemont, J. Medioni, L. Taillade, D. Helley, J.B. Meric, O. Rixe, and S. Oudard Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib Br. J. Cancer 99 2008 1380 1382
6. A. Templeton, M. Brandle, T. Cerny, and S. Gillessen Remission of diabetes while on sunitinib treatment for renal cell carcinoma Ann. Oncol. 19 2008 824 825
7. T.F. Chu, M.A. Rupnick, R. Kerkela, S.M. Dallabrida, D. Zurakowski, L. Nguyen, K. Woulfe, E. Pravda, F. Cassiola, J. Desai, S. George, J.A. Morgan, D.M. Harris, N.S. Ismail, J.H. Chen, F.J. Schoen, A.D. Van den Abbeele, G.D. Demetri, T. Force, and M.H. Chen Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib Lancet 370 2007 2011 2019
8. B.B. Hasinoff, D. Patel, and K.A. O'Hara Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib Mol. Pharmacol. 74 2008 1722 1728
9. A.Y. Khakoo, and E.T. Yeh Therapy insight: management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy Nat. Clin. Pract. Oncol. 5 2008 655 667
10. M.L. Rees, and A.Y. Khakoo Molecular mechanisms of hypertension and heart failure due to antiangiogenic cancer therapies Heart Fail. Clin. 7 2011 299 311
11. B.I. Rini, and K. Flaherty Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma Urol. Oncol. 26 2008 543 549
12. V. Chintalgattu, M.L. Rees, J.C. Culver, A. Goel, T. Jiffar, J. Zhang, K. Dunner Jr., S. Pati, J.A. Bankson, R. Pasqualini, W. Arap, N.S. Bryan, H. Taegtmeyer, R.R. Langley, H. Yao, M.E. Kupferman, M.L. Entman, M.E. Dickinson, and A.Y. Khakoo Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity Sci. Transl. Med. 5 2013 187ra169
13. A.M. Cordero-Reyes, A.A. Gupte, K.A. Youker, M. Loebe, W.A. Hsueh, G. Torre-Amione, H. Taegtmeyer, and D.J. Hamilton Freshly isolated mitochondria from failing human hearts exhibit preserved respiratory function J. Mol. Cell. Cardiol. 68 2014 98 105
14. T.D. O'Connell, M.C. Rodrigo, and P.C. Simpson Isolation and culture of adult mouse cardiac myocytes Methods Mol. Biol. 357 2007 271 296
15. C.V. Clower, D. Chatterjee, Z. Wang, L.C. Cantley, M.G. Vander Heiden, and A.R. Krainer The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism Proc. Natl. Acad. Sci. U S A 107 2010 1894 1899
16. V. Navaratnam Heart Muscle: Ultrastructural Studies 1987 Cambridge University Press New York
17. M. Rajabi, C. Kassiotis, P. Razeghi, and H. Taegtmeyer Return to the fetal gene program protects the stressed heart: a strong hypothesis Heart Fail. Rev. 12 2007 331 343
18. O. Warburg On respiratory impairment in cancer cells Science 124 1956 269 270
19. H.R. Christofk, M.G. Vander Heiden, M.H. Harris, A. Ramanathan, R.E. Gerszten, R. Wei, M.D. Fleming, S.L. Schreiber, and L.C. Cantley The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Nature 452 2008 230 233
20. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
21. Z. Gao, and T.A. Cooper Reexpression of pyruvate kinase M2 in type 1 myofibers correlates with altered glucose metabolism in myotonic dystrophy Proc. Natl. Acad. Sci. U S A 110 2013 13570 13575
22. W. Luo, H. Hu, R. Chang, J. Zhong, M. Knabel, R. O'Meally, R.N. Cole, A. Pandey, and G.L. Semenza Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1 Cell 145 2011 732 744
23. A.M. Segura, L. Dris, E.K. Massin, F.J. Clubb, L.M. Buja, O.H. Frazier, and H. Taegtmeyer Heart failure in remission for more than 13 years after removal of a left ventricular assist device Tex. Heart Inst. J. 41 2014 389 394
24. P. Razeghi, B.A. Bruckner, S. Sharma, K.A. Youker, O.H. Frazier, and H. Taegtmeyer Mechanical unloading of the failing human heart fails to activate the protein kinase B/Akt/glycogen synthase kinase-3beta survival pathway Cardiology 100 2003 17 22
25. N. Wong, J. De Melo, and D. Tang PKM2, a central point of regulation in cancer metabolism Int. J. Cell. Biol. 2013 2013 242513
26. D. Anastasiou, Y. Yu, W.J. Israelsen, J.K. Jiang, M.B. Boxer, B.S. Hong, W. Tempel, S. Dimov, M. Shen, A. Jha, H. Yang, K.R. Mattaini, C.M. Metallo, B.P. Fiske, K.D. Courtney, S. Malstrom, T.M. Khan, C. Kung, A.P. Skoumbourdis, H. Veith, N. Southall, M.J. Walsh, K.R. Brimacombe, W. Leister, S.Y. Lunt, Z.R. Johnson, K.E. Yen, K. Kunii, S.M. Davidson, H.R. Christofk, C.P. Austin, J. Inglese, M.H. Harris, J.M. Asara, G. Stephanopoulos, F.G. Salituro, S. Jin, L. Dang, D.S. Auld, H.W. Park, L.C. Cantley, C.J. Thomas, and M.G. Vander Heiden Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis Nat. Chem. Biol. 8 2012 839 847
27. S.L. Mulvagh, R. Roberts, and M.D. Schneider Cellular oncogenes in cardiovascular disease J. Mol. Cell. Cardiol. 20 1988 657 662
28. C.J. David, M. Chen, M. Assanah, P. Canoll, and J.L. Manley HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer Nature 463 2010 364 368
29. S.L. Mulvagh, L.H. Michael, M.B. Perryman, R. Roberts, and M.D. Schneider A hemodynamic load in vivo induces cardiac expression of the cellular oncogene, c-myc, Biochem. Biophys. Res. Commun. 147 1987 627 636
30. J.W. Kim, P. Gao, Y.C. Liu, G.L. Semenza, and C.V. Dang Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1 Mol. Cell. Biol. 27 2007 7381 7393
31. W. Yang, Y. Xia, H. Ji, Y. Zheng, J. Liang, W. Huang, X. Gao, K. Aldape, and Z. Lu Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation Nature 480 2011 118 122
32. X. Gao, H. Wang, J.J. Yang, X. Liu, and Z.R. Liu Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase Mol. Cell. 45 2012 598 609